Skip to main content
. 2020 Mar 19;23(17):3170–3180. doi: 10.1017/S1368980019004002

Table 1.

Participant characteristics and determinants of interest in the OaK Birth Cohort (n 7587), 2002–2009

Variable Frequency
n %
Demographic characteristics
 Age (years)
  Mean 30·3
   sd 5·06
 Race (missing/unknown, n 415, 5·5 %)
  African 152 2·12
  Middle Eastern 224 3·12
  Asian 422 5·88
  Caucasian 6250 87·1
  Other 124 1·72
 College/university completed (missing, n 7, 0·09 %)
  Yes 5711 75·3
  No 1869 24·6
 Household income in CAD (missing, n 485, 6·4 %)
  <$50 000 1603 22·6
  $50 000–<80 000 5499 77·4
Health indicators
 BMI (missing, n 136, 1·8 %)
  Mean 24·9
  sd 5·49
 Diabetes (missing, n 61, 0·80 %)
  Yes 115 1·53
  No 7411 98·5
 Chronic hypertension (missing, n 64, 0·84 %)
  Yes 91 1·21
  No 7432 98·8
Pregnancy characteristics
 Nulliparous (missing, n 738, 9·7 %)
  Yes 3059 44·7
  No 3790 55·3
 Smoking during pregnancy (missing, n 26, 0·34 %)
  No 6714 88·8
  Second-hand exposure 148 1·96
  Medium/light smoker (<10 cigarettes per day) 449 5·93
  Heavy smoker (≥10 cigarettes per day) 250 3·31
 Hormonal birth control prior to conception (missing, n 45, 0·59 %)
  Yes 2749 36·6
  No 4783 63·4
 History of a placenta-mediated complication (pre-eclampsia, placental abruption, SGA, pregnancy loss) (missing, n 4, 0·053 %)
  Yes 794 10·5
  No 6789 89·5
 Any folic acid supplementation (folic acid alone or from prenatal vitamin or from multivitamins) (missing, n 1, 0·01 %)
  Yes 7184 94·7
  No 402 5·30
 Folic acid dose (mg) (missing, n 242, 3·19 %)
  0 402 5·47
  >0 and ≤1 5876 80·0
  >1 1067 14·5
Homocysteine metabolism
 Gestational age at bloodwork (weeks)
  Mean 13·7
  sd 2·09
 Homocysteine (µmol/l) (missing, n 87, 1·1 %)
  Mean 4·8
  sd 1·3
  Range 1–34
 Serum folate (nmol/l) (missing, n 987, 13·0 %)
  Median 37·4
  IQR 30·6–45·1
  Range 3·70–79·6
 MTHFR genotype* n 4006
  CC (wild-type) 1768 44·1
  CT (heterozygous) 1760 43·9
  TT (homozygous) 478 11·9
*

Measured in a subset of participants (n 4006).